HC
AGIO icon

Hurley Capital’s Agios Pharmaceuticals AGIO Stock Holding History

Hurley Capital’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.45K Hold
120
– – ﹤0.01% 463
2026
Q1 		$4.06K Sell
120
-366
-75% -$10.4K ﹤0.01% 480
2025
Q4 		$13.2K Buy
486
+120
+33% +$4.21K 0.01% 301
2025
Q3 		$14.7K Hold
366
– – 0.01% 317
2025
Q2 		$12.2K Hold
366
– – 0.01% 289
2025
Q1 		$10.7K Buy
+366
New +$12.1K 0.01% 315

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Hurley Capital's AGIO Position: Q2 2026 in Review

Hurley Capital held its Agios Pharmaceuticals (AGIO) position steady in Q2 2026 at 120 shares worth $4.45K. The position accounts for ﹤0.01% of the portfolio, ranked #463.

Hurley Capital first reported a position in AGIO in Q1 2025 and has held it in 6 quarters since. The position peaked at $14.7K in Q3 2025. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Hurley Capital held 120 shares of Agios Pharmaceuticals worth $4.45K as of Q2 2026.
  • Hurley Capital left its Agios Pharmaceuticals share count unchanged in Q2 2026.
  • Agios Pharmaceuticals made up ﹤0.01% of Hurley Capital's portfolio in Q2 2026, its #463 holding.
  • Hurley Capital first reported a position in Agios Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Hurley Capital's Agios Pharmaceuticals position peaked at $14.7K in Q3 2025.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Hurley Capital's 13F filing for Q2 2026, filed 10 Aug 2026.